ATOS Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Atossa Therapeutics Inc (ATOS) is not a strong buy for a beginner, long-term investor at this time. The stock exhibits bearish technical indicators, lacks significant positive catalysts, and has no recent signals from Intellectia Proprietary Trading Signals. While the company has raised funds recently, the stock's performance and sentiment do not currently align with a strong long-term investment opportunity.
The stock is in a bearish trend with the MACD histogram at -0.27, RSI at 6.633 indicating oversold conditions, and bearish moving averages (SMA_200 > SMA_20 > SMA_5). Key support and resistance levels show potential downside risk with S1 at 2.209 and S2 at 1.537.
The company recently raised $4.5 million through a registered direct offering and has potential additional proceeds of $12 million if warrants are exercised.
The stock has a 60% chance to decline by -2.71% in the next day, -6.41% in the next week, and -12.15% in the next month. Bearish technical indicators and lack of significant trading trends from hedge funds or insiders further dampen sentiment.
No financial data available for analysis due to an error in the provided data.
H.C. Wainwright adjusted the price target to $25 from $7, citing a 1-for-15 reverse stock split. The rating remains a Buy, but the reverse split may indicate underlying challenges.
